P
Peter Moritz Becher
Researcher at Charité
Publications - 49
Citations - 2021
Peter Moritz Becher is an academic researcher from Charité. The author has contributed to research in topics: Heart failure & Medicine. The author has an hindex of 18, co-authored 38 publications receiving 1314 citations. Previous affiliations of Peter Moritz Becher include University of Hamburg.
Papers
More filters
Journal ArticleDOI
Myocardial Titin Hypophosphorylation Importantly Contributes to Heart Failure with Preserved Ejection Fraction in a Rat Metabolic Risk Model
Nazha Hamdani,Constantijn Franssen,André P. Lourenço,Inês Falcão-Pires,Dulce Fontoura,Sara Leite,Luisa Plettig,Begoña López,Coen A.C. Ottenheijm,Peter Moritz Becher,Arantxa González,Carsten Tschöpe,Javier Díez,Wolfgang A. Linke,Adelino F. Leite-Moreira,Walter Paulus +15 more
TL;DR: Obese ZSF1 rats developed heart failure with preserved ejection fraction during a 20-week time span, and titin hypophosphorylation importantly contributed to the underlying myocardial DD.
Journal ArticleDOI
Left Ventricular Unloading Is Associated With Lower Mortality in Patients With Cardiogenic Shock Treated With Venoarterial Extracorporeal Membrane Oxygenation: Results From an International, Multicenter Cohort Study.
Benedikt Schrage,Peter Moritz Becher,Alexander M. Bernhardt,Hiram G. Bezerra,Stefan Blankenberg,Stefan Brunner,Pascal Colson,Gaston A Cudemus Deseda,Salim Dabboura,Dennis Eckner,Matthias Eden,Ingo Eitel,Derk Frank,Norbert Frey,Masaki Funamoto,Alina Goßling,Tobias Graf,Christian Hagl,Paulus Kirchhof,Danny Kupka,Ulf Landmesser,Jerry Lipinski,Mathew S Lopes,Nicolas Majunke,Octavian Maniuc,Daniel Mcgrath,Sven Möbius-Winkler,David A. Morrow,Marc Mourad,Curt Noel,Peter Nordbeck,Martin Orban,Federico Pappalardo,Federico Pappalardo,Sandeep M. Patel,Matthias Pauschinger,Vittorio Pazzanese,Hermann Reichenspurner,Marcus Sandri,P. Christian Schulze,Robert H. G. Schwinger,Jan Malte Sinning,Adem Aksoy,Carsten Skurk,Lukasz Szczanowicz,Holger Thiele,Franziska Tietz,Anubodh S. Varshney,Lukas Wechsler,Dirk Westermann +49 more
Abstract: Background: Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is increasingly used to treat cardiogenic shock. However, VA-ECMO might hamper myocardial recovery. The Impella unloads the le...
Journal ArticleDOI
Global burden of heart failure: A comprehensive and updated review of epidemiology.
Gianluigi Savarese,Peter Moritz Becher,Lars Lund,Petar M. Seferović,Giuseppe M.C. Rosano,Andrew J.S. Coats +5 more
TL;DR: A contemporary overview on the global burden of HF is provided, providing updated estimates on prevalence, incidence, outcomes, and costs worldwide.
Journal ArticleDOI
Pretreatment with Statin Attenuates the Cardiotoxicity of Doxorubicin in Mice
Alexander Riad,Sandra Bien,Dirk Westermann,Peter Moritz Becher,Komal Loya,Ulf Landmesser,Heyo K. Kroemer,Heinz P. Schultheiss,Carsten Tschöpe +8 more
TL;DR: Investigating whether or not fluvastatin pretreatment can attenuate doxorubicin-induced cardiotoxicity via antioxidative and anti-inflammatory effects found it to be possible.
Journal ArticleDOI
Application of the SCAI classification in a cohort of patients with cardiogenic shock.
Benedikt Schrage,Salim Dabboura,Isabell Yan,Rafel Hilal,Johannes T Neumann,Nils A Sörensen,Alina Goßling,Peter Moritz Becher,Hanno Grahn,Tobias Wagner,Moritz Seiffert,Stefan Kluge,Hermann Reichenspurner,Stefan Blankenberg,Dirk Westermann +14 more
TL;DR: The Society of Cardiovascular Angiography and Interventions (SCAI) have recently proposed a new classification of cardiogenic shock dividing patients into five subgroups.